Human immunodeficiency virus-associated dementia: an evolving disease.
about
Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief OverviewPaving the path to HIV neurotherapy: Predicting SIV CNS diseaseHIV Associated Neurocognitive DisordersNeuropathogenesis of HIV-1-associated neurocognitive disorders: a possible involvement of D-serineMechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disordersTranscriptome sequencing of gene expression in the brain of the HIV-1 transgenic rat.Modulation Effect of HIV-1 Viral Proteins and Nicotine on Expression of the Immune-Related Genes in Brain of the HIV-1 Transgenic Rats.Neuropsychological Dysfunction among HIV Infected Drug AbusersThe longitudinal and interactive effects of HIV status, stimulant use, and host genotype upon neurocognitive functioning.Acquisition and long-term retention of spatial learning in the human immunodeficiency virus-1 transgenic rat: effects of repeated nicotine treatment.RNA deep sequencing analysis reveals that nicotine restores impaired gene expression by viral proteins in the brains of HIV-1 transgenic ratsPattern of neuropsychological performance among HIV positive patients in Uganda.Potential utility of resting-state magnetoencephalography as a biomarker of CNS abnormality in HIV disease.PET brain imaging in HIV-associated neurocognitive disorders (HAND) in the era of combination antiretroviral therapy.Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients.Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIV.Nuclear factor-kappa B family member RelB inhibits human immunodeficiency virus-1 Tat-induced tumor necrosis factor-alpha production.Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review.Reduced genetic diversity in lymphoid and central nervous system tissues and selection-induced tissue-specific compartmentalization of neuropathogenic SIVsmmFGb during acute infection.Interaction with CD4 and antibodies to CD4-induced epitopes of the envelope gp120 from a microglial cell-adapted human immunodeficiency virus type 1 isolateHIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications.Genetic variation and HIV-associated neurologic disease.Minocycline inhibition of monocyte activation correlates with neuronal protection in SIV neuroAIDSIncreased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementiaImpact of short-term combined antiretroviral therapy on brain virus burden in simian immunodeficiency virus-infected and CD8+ lymphocyte-depleted rhesus macaques.HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope.Lessons learned developing a diagnostic tool for HIV-associated dementia feasible to implement in resource-limited settings: pilot testing in Kenya.Metabolic and neurologic consequences of chronic lopinavir/ritonavir administration to C57BL/6 miceHigher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 CohortPlatelet-derived growth factor CC-mediated neuroprotection against HIV Tat involves TRPC-mediated inactivation of GSK 3beta.Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based studyVoltage-gated potassium channels in human immunodeficiency virus type-1 (HIV-1)-associated neurocognitive disorders.The role of medical imaging in defining CNS abnormalities associated with HIV-infection and opportunistic infectionsIncreased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with Roscovitine.Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disorders.Circulating proviral HIV DNA and HIV-associated dementia.Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies.
P2860
Q26770401-A8938CA9-C24F-4C9E-9A3C-CF31190F3C00Q26852969-B80F3A55-A801-4B33-944E-04B7A7C1DC92Q27023968-94F43774-DC0D-4577-A0FC-31C50F9CA306Q27024914-D5E692BA-7AC3-461F-BFCD-2A78BD07CD32Q28082139-AF9F322C-96C8-4CA7-A64B-BB886FC5D6B3Q28488809-E6C47F18-73E0-4E39-9A66-AD0BB7BE6396Q30276862-A8C76B90-EDE3-4749-8435-F34944EB2C5EQ30389107-B6638B42-9FB0-4A46-AC26-4E65EE04BA7AQ30410418-86BC32B2-D992-444C-BADA-241B124E0832Q30414070-1C6807DD-A8C3-4DFB-AAE4-CB7F9A658813Q30418181-4C4B5343-D8AA-4C2E-99C9-87A08ADE2689Q30445074-16FEA2D7-9824-4C6F-B5F4-0CA7EDA1A32AQ30513406-A6002543-A62D-48CE-BA63-A0651834B69CQ31153188-FCE741BA-5836-4047-B6B5-4C09EB87EA99Q33311631-DF64BFFF-0FA7-4CB9-A990-DD1408D6358BQ33346244-5781CFDE-4391-4DAF-AE1E-82C70DB8AAFAQ33637117-F366FBFE-3770-4FA0-B5DD-1109E325D38CQ33649838-31F87F85-3DCB-43C0-BC4F-1DB306E4CE33Q33716348-D19F6883-5772-4519-A792-79176C199123Q33753132-F729A6F7-7DBD-4184-A45A-D2D161990405Q33786216-1C201EB6-975B-463A-B0DC-6D5AF1685F64Q33788874-AA4A27FB-E3F4-4721-83B5-C866DB45D2B7Q33805298-071E180D-EE43-4D41-AB6C-54BC963BD245Q33819189-E934F25A-D2E1-4BA5-9EFC-EB8856001111Q33873798-E2F225E2-4E5F-4B7A-9139-D226033C7287Q33911855-5D170976-ED2F-41B9-898A-B70989553AE7Q34033558-3C3E1BA0-703B-4E62-B624-A343659DA84FQ34037622-E850F248-8431-4640-BD69-BE40FBA14D90Q34091371-9C13FF82-25F8-445E-B090-43DE0D568ED8Q34193503-2ACD8520-4B15-4638-AFEB-6A4006EC05B7Q34349192-505DA958-B90F-4B68-AAB5-4538A99254AEQ34406750-E9F56FDD-432B-4882-878B-4341C3EF4211Q34450960-4FD04834-7776-43D9-AE1E-37B74BF7D3F0Q34455156-0077D751-5E77-4A1A-B840-1592FBBE53A9Q34776120-A3825EE3-B63D-49BC-8BFC-9DC41EDCBB1BQ34787585-BAF3B0F5-106A-4416-B5F7-AE40781CB1E2Q34805533-9F673401-E9C3-4E28-A503-F627AC4A7006Q34914245-BB44B478-BB98-47C4-A008-67863C1AD887Q35012478-DC6DD229-5C62-4BF7-ABC7-BF16E55B2F85Q35023780-AEA59F34-9DD0-4ECD-A689-1E8765BB7186
P2860
Human immunodeficiency virus-associated dementia: an evolving disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Human immunodeficiency virus-associated dementia: an evolving disease.
@ast
Human immunodeficiency virus-associated dementia: an evolving disease.
@en
type
label
Human immunodeficiency virus-associated dementia: an evolving disease.
@ast
Human immunodeficiency virus-associated dementia: an evolving disease.
@en
prefLabel
Human immunodeficiency virus-associated dementia: an evolving disease.
@ast
Human immunodeficiency virus-associated dementia: an evolving disease.
@en
P2093
P1476
Human immunodeficiency virus-associated dementia: an evolving disease.
@en
P2093
Carlos Pardo
Justin C McArthur
Kathy Conant
Norman Haughey
Suzanne Gartner
P2888
P304
P356
10.1080/13550280390194109
P50
P577
2003-04-01T00:00:00Z
P5875
P6179
1052280988